Clinical Trial Update: Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating lenalidomide (Revlimid) in combination with pegylated liposomal doxorubicin (Doxil) and bevacizumab (Avastin) in platinum-resistant ova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Carcinoma
• Ovarian Cancer
• Peritoneal Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Doxil (liposomal doxorubicin)
• Revlimid (lenalidomide)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Ovarian Cancer, Epithelial Ovarian Cancer | Phase 1 | Status: TERMINATED